Verastem Inc (VSTM)

Apr 02, 2025

Verastem Oncology Reports Progress in Cancer Treatments - TipRanks

Apr 02, 2025

Mar 28, 2025

Verastem (NASDAQ:VSTM) Upgraded at StockNews.com - MarketBeat

Mar 28, 2025

Mar 27, 2025

Wall Street Analysts Believe Verastem (VSTM) Could Rally 100.94%: Here's is How to Trade - Yahoo Finance

Mar 27, 2025

Mar 27, 2025

(VSTM) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Mar 27, 2025

Mar 25, 2025

Verastem Oncology Announces Multiple Presentations Focused on RAS/MAPK Pathway Inhibition at AACR Annual Meeting 2025 - Yahoo Finance

Mar 25, 2025

Mar 24, 2025

Verastem CFO Daniel Calkins sells shares worth $630 - Investing.com India

Mar 24, 2025

Mar 24, 2025

Verastem CFO Daniel Calkins sells shares worth $630 By Investing.com - Investing.com Australia

Mar 24, 2025

Mar 24, 2025

H.C. Wainwright lifts Verastem stock price target to $10 By Investing.com - Investing.com Canada

Mar 24, 2025

Mar 24, 2025

Guggenheim lifts Verastem stock target to $14, maintains buy By Investing.com - Investing.com Canada

Mar 24, 2025

Mar 24, 2025

H.C. Wainwright lifts Verastem stock price target to $10 - Investing.com India

Mar 24, 2025

Mar 23, 2025

Royal Bank of Canada Lowers Verastem (NASDAQ:VSTM) Price Target to $14.00 - Defense World

Mar 23, 2025

Mar 21, 2025

RBC Cuts Price Target on Verastem to $14 From $16, Maintains Outperform Rating -March 21, 2025 at 08:40 am EDT - Marketscreener.com

Mar 21, 2025

Mar 21, 2025

BTIG maintains $20 target, Buy rating on Verastem stock By Investing.com - Investing.com Canada

Mar 21, 2025

Mar 21, 2025

Verastem: Q4 Earnings Snapshot - Midland Daily News

Mar 21, 2025

Mar 20, 2025

Verastem director Brian Stuglik sells shares worth $4,121 By Investing.com - Investing.com Australia

Mar 20, 2025

Mar 20, 2025

Verastem Unveils Strategic Plans in New Presentation - TipRanks

Mar 20, 2025

Mar 20, 2025

Verastem Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025

Mar 20, 2025

Verastem, Inc. SEC 10-K Report - TradingView

Mar 20, 2025

Mar 20, 2025

Verastem Inc. (VSTM) reports earnings - Quartz

Mar 20, 2025

Mar 20, 2025

Verastem Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates - Bluefield Daily Telegraph

Mar 20, 2025

Mar 20, 2025

Verastem director Robert Gagnon sells shares worth $1,973 By Investing.com - Investing.com Australia

Mar 20, 2025

Mar 20, 2025

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mar 20, 2025

Mar 20, 2025

Verastem, Inc. (NASDAQ:VSTM) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Mar 20, 2025

Mar 19, 2025

Verastem CEO sells shares worth $1,695 By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Verastem director Robert Gagnon sells shares worth $1,973 - Investing.com

Mar 19, 2025

Mar 19, 2025

Verastem director Brian Stuglik sells shares worth $4,121 - Investing.com

Mar 19, 2025

Mar 19, 2025

Verastem (NASDAQ:VSTM) Stock Passes Above 200-Day Moving Average – Here’s Why - Defense World

Mar 19, 2025

Mar 18, 2025

Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Mar 18, 2025

Mar 14, 2025

Verastem Inc expected to post a loss of 81 cents a shareEarnings Preview - TradingView

Mar 14, 2025

Mar 13, 2025

Verastem to Present at Keystone Symposia on PI3 Kinase - AOL.com

Mar 13, 2025

Mar 11, 2025

Verastem: Upcoming PDUFA, But I Remain Cautious (NASDAQ:VSTM) - Seeking Alpha

Mar 11, 2025

Mar 11, 2025

Rhumbline Advisers Acquires 10,352 Shares of Verastem, Inc. (NASDAQ:VSTM) - Defense World

Mar 11, 2025

Mar 08, 2025

Why the Global Cancer Market Could Surpass $900 Billion-And the Stocks Leading the Charge - The Malaysian Reserve

Mar 08, 2025

Mar 08, 2025

Why the Global Cancer Market Could Surpass $900 Billion—And the Stocks Leading the Charge - Morningstar

Mar 08, 2025

Mar 06, 2025

Verastem (VSTM) Expected to Announce Earnings on Thursday - Defense World

Mar 06, 2025

Mar 06, 2025

Objective long/short (VSTM) Report - Stock Traders Daily

Mar 06, 2025

Mar 05, 2025

Verastem Inc (NASDAQ: VSTM) Stock Forecast: Bearish Expectations Portend -120.34% Downside In 2025 - Stocks Register

Mar 05, 2025

Mar 04, 2025

Verastem (NASDAQ:VSTM) Stock Price Passes Above 200 Day Moving Average – Should You Sell? - Defense World

Mar 04, 2025

Feb 23, 2025

Verastem, Inc. (NASDAQ:VSTM) Given Consensus Rating of “Buy” by Brokerages - Defense World

Feb 23, 2025

Feb 20, 2025

Verastem Oncology Announces Multiple Data Presentations At Society Of Gynecologic Oncology 2025 Annual Meeting On Women's Cancer - Marketscreener.com

Feb 20, 2025

Feb 20, 2025

Verastem Oncology Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer - Business Wire

Feb 20, 2025

Feb 19, 2025

VSTM Up as NDA for Ovarian Cancer Combo Gets FDA's Priority Review Tag - MSN

Feb 19, 2025

Feb 13, 2025

When the Price of (VSTM) Talks, People Listen - Stock Traders Daily

Feb 13, 2025

Feb 10, 2025

Financial Snapshot: Analyzing Verastem Inc (VSTM)’s Key Ratio Metrics - The Dwinnex

Feb 10, 2025

Feb 08, 2025

Verastem Inc (NASDAQ: VSTM) Shares Fall By -4.77 Percent In The Past Week, But How Long Will It Last? - Marketing Sentinel

Feb 08, 2025